Long-term use of osteoporosis drugs may have risk
March 10, 2010 (WLS) -- The government is reviewing certain bone-building drugs to see if they increase the risk of femur fractures.
The Food and Drug Administration will look into four drugs used to treat osteoporosis: Fosomax, Actonel, Boniva and Reclast. The drugs are commonly prescribed to treat osteoporosis and build bone mass.
The FDA is also asking doctors to report any side effects seen with the medications.
Some doctors say patients currently taking the medications should not stop taking them because the benefits outweigh the risk.
"The risk benefit is still in a woman's favor to stay on a bisphosphonate to avoid fractures of the spine or the typical hip fracture. Because the morbidity mortality rate of hip fractures is especially in older women is just huge," said Dr. Sheila Dugan, Rush University.
Dr. Dugan says people with thigh or hip bone pains should consider getting an MRI because those symptoms may indicate that the bone is weakening before it breaks.
- Winning Powerball numbers announced 42 min ago
- Teachers march to protest proposed school closings
- Video: Monday @ 10: Expanded Gambling
- ABC7 Weather Forecast 45 min ago
- 12 arrested after rowdiness reports near Michigan Avenue
- Blackhawks fall to Red Wings 4-1, series evened, 1-1
- Triple Crown spoiled; Oxbow upsets Orb
- Illinois Lottery bounced checks for 8 winners
- Official: 50 to 60 injured in Virginia parade crash
- 2 split $190M Mega Millions jackpot
- Shootings leave 3 dead, several injured
- Man charged with recording video in hospital bathroom
- Coast Guard reminding boaters of maritime safety
- abcnews: 13 Weird Things You Can Buy With Bitcoin
- ABC7 Weather Forecast
45 min ago